Stock ASLN ASLAN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News ASLAN Pharmaceuticals Limited

Equities

ASLN

US04522R2004

Delayed Nasdaq
Other stock markets
 10:17:17 2024-05-10 am EDT 		5-day change 1st Jan Change
0.41 USD -2.33% Intraday chart for ASLAN Pharmaceuticals Limited -6.62% -20.03%
May. 09 ASLAN Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 08 Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ASLAN Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
MT
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
AQ
Aslan Pharmaceuticals to Present Additional Data from Interim Analysis of Trek-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
CI
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Monday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher
MT
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
MT
ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
AQ
ASLAN Pharmaceuticals Announces Expansion of its Collaboration with Zenyaku Kogyo Co., Ltd. to Investigate Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
CI
Asian Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
MT
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
AQ
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note in Monday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%
MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
MT
ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
AQ
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher
MT
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice - April 19, 2024
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASLN Stock
  4. News ASLAN Pharmaceuticals Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW